Men’s Performance & Recovery Research Series

The metabolic research space is evolving faster than ever. For years, most obesity and weight-management discussions centered around injectable GLP-1 therapies. But now, researchers are increasingly exploring oral compounds connected to: Two compounds that continue generating significant attention in these conversations are orforglipron and tesofensine. While they work through very different mechanisms, both are becoming…

The combination of Retatrutide and MOTS-C is being explored in research for its ability to target multiple layers of metabolic function at the same time. Key Research Benefits: • Dual-pathway approach Retatrutide works on whole-body metabolic signaling, while MOTS-C focuses on cellular and mitochondrial energy systems. • Enhanced energy regulation models This combination allows researchers…